Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Oncol Rep ; 32(2): 709-15, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24898785

ABSTRACT

The present study aimed to prospectively monitor the vascular disrupting effect of M410 by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in rabbits with VX2 liver tumors. Twenty-eight rabbits bearing VX2 tumors in the left lobe of the liver were established and randomly divided into treatment and control groups, intravenously injected with 25 mg/kg M410 or sterile saline, respectively. Conventional and DCE-MRI data were acquired on a 3.0-T MR unit at pretreatment, 4 h, 1, 4, 7 and 14 days post-treatment. Histopathological examinations [hematoxylin and eosin (H&E) and CD34 immunohistochemisty staining] were performed at each time point. The dynamic changes in tumor volume, kinetic DCE-MRI parameter [volume transfer constant (Ktrans)] and histological data were evaluated. Tumors grew slower in the M410 group 4-14 days following treatment, compared with rapidly growing tumors in the control group (P<0.05). At 4 h, 1 and 4 days, Ktrans significantly decreased in the M410 group compared with that in the control group (P<0.05). However, Ktrans values were similar in the two groups for the other time points studied. The changes in DCE-MRI parameters were consistent with the results obtained from H&E and CD34 staining of the tumor tissues. DCE-MRI parameter Ktrans may be used as a non-invasive imaging biomarker to monitor the dynamic histological changes in tumors following treatment with the vascular targeting agent M410.


Subject(s)
Angiogenesis Inhibitors/administration & dosage , Bibenzyls/administration & dosage , Liver Neoplasms, Experimental/pathology , Magnetic Resonance Imaging/methods , Organophosphates/administration & dosage , Stilbenes/administration & dosage , Angiogenesis Inhibitors/chemical synthesis , Angiogenesis Inhibitors/pharmacokinetics , Animals , Bibenzyls/chemical synthesis , Bibenzyls/pharmacokinetics , Biomarkers, Tumor/metabolism , Cell Line, Tumor , Liver Neoplasms, Experimental/drug therapy , Male , Organophosphates/chemical synthesis , Organophosphates/pharmacokinetics , Rabbits , Stilbenes/chemical synthesis , Stilbenes/pharmacokinetics
2.
Antimicrob Agents Chemother ; 58(4): 2344-55, 2014.
Article in English | MEDLINE | ID: mdl-24514088

ABSTRACT

Pterostilbene (PTE) is a stilbene-derived phytoalexin that originates from several natural plant sources. In this study, we evaluated the activity of PTE against Candida albicans biofilms and explored the underlying mechanisms. In 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduction assays, biofilm biomass measurement, confocal laser scanning microscopy, and scanning electron microscopy, we found that ≤16 µg/ml PTE had a significant effect against C. albicans biofilms in vitro, while it had no fungicidal effect on planktonic C. albicans cells, which suggested a unique antibiofilm effect of PTE. Then we found that PTE could inhibit biofilm formation and destroy the maintenance of mature biofilms. At 4 µg/ml, PTE decreased cellular surface hydrophobicity (CSH) and suppressed hyphal formation. Gene expression microarrays and real-time reverse transcription-PCR showed that exposure of C. albicans to 16 µg/ml PTE altered the expression of genes that function in morphological transition, ergosterol biosynthesis, oxidoreductase activity, and cell surface and protein unfolding processes (heat shock proteins). Filamentation-related genes, especially those regulated by the Ras/cyclic AMP (cAMP) pathway, including ECE1, ALS3, HWP1, HGC1, and RAS1 itself, were downregulated upon PTE treatment, indicating that the antibiofilm effect of PTE was related to the Ras/cAMP pathway. Then, we found that the addition of exogenous cAMP reverted the PTE-induced filamentous growth defect. Finally, with a rat central venous catheter infection model, we confirmed the in vivo activity of PTE against C. albicans biofilms. Collectively, PTE had strong activities against C. albicans biofilms both in vitro and in vivo, and these activities were associated with the Ras/cAMP pathway.


Subject(s)
Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Biofilms/drug effects , Candida albicans/drug effects , Candida albicans/physiology , Stilbenes/pharmacology , Stilbenes/therapeutic use , Animals , Candida albicans/metabolism , Female , Fungal Proteins/metabolism , Microbial Sensitivity Tests , Microscopy, Electron, Scanning , Rats , Rats, Sprague-Dawley
3.
Org Biomol Chem ; 11(40): 6967-74, 2013 Sep 25.
Article in English | MEDLINE | ID: mdl-24057265

ABSTRACT

A series of trans- or cis-stilbenes have been synthesized in good to excellent yields via a functional group-dependent decarboxylation process from the corresponding 2,3-diaryl acrylic acids in a neutral CuI/1,10-phen/PEG-400 system under microwave conditions. The in situ generation of the recyclable catalytic complex, the use of environmentally benign solvent PEG-400, the operational simplicity, the short reaction times, as well as the functional group-dependent chemo- and stereo-selectivity have made the decarboxylation process a highly efficient and applicable protocol.


Subject(s)
Acrylates/chemistry , Copper/chemistry , Iodides/chemistry , Microwaves , Phenanthrolines/chemistry , Polyethylene Glycols/chemistry , Stilbenes/chemical synthesis , Catalysis , Decarboxylation , Molecular Structure , Organometallic Compounds/chemistry , Stereoisomerism , Stilbenes/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...